On the TRAIL of therapeutic antibody treatments
Monoclonal antibodies are important research tools in the fight against cancer.But they have also proven to be powerful therapeutic tools in their own right,owing to their ability to target specific proteins expressed by tumour cells. Recently,researchers at the Wistar Institute used TRAIL antibody products to develop a new combination therapy for malignant brain tumors.